Clinical trial Recruiting at 1 site Interventional Ages 16 to 40

Comparing two surgical methods for shoulder dislocation treatment

Official title: Latarjet vs Anatomic Glenoid Reconstruction for Treatment of Anterior Shoulder Instability With Glenoid Bone Loss: a Prospective Multi-centre Randomized Trial

Run by Nova Scotia Health Authority · NCT05658289 · Data updated 2026-11-12

This study is testing which of two shoulder surgeries, the Latarjet procedure or Anatomic Glenoid Reconstruction, works better for people with significant bone loss after multiple dislocations.

Quick facts

Study typeInterventional
Ages16 Years to 40 Years
SexAll
Enrollment68 (estimated)
SponsorNova Scotia Health Authority
Academic / other
Locations1 site (Halifax, Nova Scotia)
StatusRecruiting
StartedApril 24, 2023
Main results expectedJanuary 2026
Study endsDecember 2026
Registry record updatedAugust 22, 2024
Trial IDNCT05658289 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals who have experienced anterior shoulder dislocations and have significant glenoid bone loss as indicated by imaging.

Probably not a fit

Patients with posterior or multidirectional shoulder instability, massive rotator cuff tears, or those unable to provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial compares the effectiveness of the Latarjet procedure and Anatomic Glenoid Reconstruction (AGR) in treating anterior shoulder dislocations with significant bone loss. Both surgical techniques aim to reduce the risk of recurrent dislocations and improve patient outcomes, including pain relief and functional recovery. The study involves patients who have experienced one or more shoulder dislocations and have a pre-operative CT scan showing over 20% bone loss. Participants will be randomly assigned to receive either the Latarjet or AGR intervention.

Why it matters

Potential benefit: If successful, this study could provide patients with a more effective surgical option for preventing recurrent shoulder dislocations.

How similar studies have gone: Previous studies have shown success with both the Latarjet and AGR approaches, but this trial aims to directly compare their outcomes in a controlled setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with one or more instances of anterior shoulder dislocation; pre-operative CT scan illustrating \>20% bone loss.

Exclusion Criteria:

* posterior shoulder instability; multidirectional shoulder instability; massive rotator cuff teats (MRI proven); history of substance abuse, patients unable to provide informed consent, patients refusing randomization.

Where it's running

  • Nova Scotia Health QEII Halifax Infirmary
    Halifax, Nova Scotia, Canada
    Recruiting

Study contacts

  • Principal investigator: Ivan Wong, MD — Nova Scotia Health Authority, Orthopaedic Surgeon
  • Study coordinator: Ivan Wong, MD
  • Email: research@drivanwong.com
  • Phone: 9024737626

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.